Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 468637
                    [Title] => GSK launches new allergic rhinitis treatment
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

FUROATE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 468637
                    [Title] => GSK launches new allergic rhinitis treatment
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

GSK launches new allergic rhinitis treatment

May 19, 2009 - 12:00am

MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).

Health And Family